News

The transaction will continue to bolster Hi-Tech’s leading Sports Nutrition and Weight Loss arsenal and expand its position as the leader in Diet & Energy products in the

Under the collaboration, Celgene will have the option to license histone methyltransferase (HMT) inhibitors being developed by Epizyme against three predefined targets. Under the terms of the revised

In order to address the need, BARDA, in consultation with the FDA’s Drug Shortage Staff, selected several products from the (FDA) Drug Shortage Index, for the network contractors

EASE LID is a confirmatory trial designed to evaluate the efficacy and safety of ADS-5102 for the treatment of levodopa-induced dyskinesia (LID), a motor complication associated with the

HuATN-658 is designed to target the cell surface protein uPAR, which is found in high levels in some of the most deadly cancers. As part of the deal,

The launch of this product follows receipt of the final approval from the US Food and Drug Administration (FDA) for an abbreviated new drug application (ANDA). IGI Laboratories

For Trulicity, Eli Lilly Japan has secured a manufacturing/marketing license as a drug indicated to treat people with type 2 diabetes in Japan. Trulicity is a once-weekly glucagon-like

The BLA for daratumumab is to treat MM patients who have received at least three prior lines of therapy including both a proteasome inhibitor (PI) and an immunomodulatory

Bexarotene 75mg capsules are a generic version of Valeant’s Targretin Capsules. Mylan CEO Heather Bresch said: "Mylan’s launch of the first and only generic Targretin is another example